FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2529168807> ?p ?o ?g. }

• W2529168807 endingPage "1523" @default.
• W2529168807 startingPage "1513" @default.
• W2529168807 abstract "Zika virus (ZIKV) infection has been linked to the Guillain-Barré syndrome. From November 2015 through March 2016, clusters of cases of the Guillain-Barré syndrome were observed during the outbreak of ZIKV infection in Colombia. We characterized the clinical features of cases of Guillain-Barré syndrome in the context of this ZIKV infection outbreak and investigated their relationship with ZIKV infection.A total of 68 patients with the Guillain-Barré syndrome at six Colombian hospitals were evaluated clinically, and virologic studies were completed for 42 of the patients. We performed reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assays for ZIKV in blood, cerebrospinal fluid, and urine, as well as antiflavivirus antibody assays.A total of 66 patients (97%) had symptoms compatible with ZIKV infection before the onset of the Guillain-Barré syndrome. The median period between the onset of symptoms of ZIKV infection and symptoms of the Guillain-Barré syndrome was 7 days (interquartile range, 3 to 10). Among the 68 patients with the Guillain-Barré syndrome, 50% were found to have bilateral facial paralysis on examination. Among 46 patients in whom nerve-conduction studies and electromyography were performed, the results in 36 patients (78%) were consistent with the acute inflammatory demyelinating polyneuropathy subtype of the Guillain-Barré syndrome. Among the 42 patients who had samples tested for ZIKV by RT-PCR, the results were positive in 17 patients (40%). Most of the positive RT-PCR results were in urine samples (in 16 of the 17 patients with positive RT-PCR results), although 3 samples of cerebrospinal fluid were also positive. In 18 of 42 patients (43%) with the Guillain-Barré syndrome who underwent laboratory testing, the presence of ZIKV infection was supported by clinical and immunologic findings. In 20 of these 42 patients (48%), the Guillain-Barré syndrome had a parainfectious onset. All patients tested were negative for dengue virus infection as assessed by RT-PCR.The evidence of ZIKV infection documented by RT-PCR among patients with the Guillain-Barré syndrome during the outbreak of ZIKV infection in Colombia lends support to the role of the infection in the development of the Guillain-Barré syndrome. (Funded by the Bart McLean Fund for Neuroimmunology Research and others.)." @default.
• W2529168807 created "2016-10-14" @default.
• W2529168807 creator A5004411977 @default.
• W2529168807 creator A5006848901 @default.
• W2529168807 creator A5009530648 @default.
• W2529168807 creator A5009670740 @default.
• W2529168807 creator A5016803527 @default.
• W2529168807 creator A5019448758 @default.
• W2529168807 creator A5021863965 @default.
• W2529168807 creator A5032912238 @default.
• W2529168807 creator A5034754979 @default.
• W2529168807 creator A5035047139 @default.
• W2529168807 creator A5040987821 @default.
• W2529168807 creator A5042412197 @default.
• W2529168807 creator A5048048876 @default.
• W2529168807 creator A5053007723 @default.
• W2529168807 creator A5054373500 @default.
• W2529168807 creator A5055603714 @default.
• W2529168807 creator A5062797338 @default.
• W2529168807 creator A5067236730 @default.
• W2529168807 creator A5086053655 @default.
• W2529168807 creator A5087193991 @default.
• W2529168807 date "2016-10-20" @default.
• W2529168807 modified "2023-10-06" @default.
• W2529168807 title "Guillain–Barré Syndrome Associated with Zika Virus Infection in Colombia" @default.
• W2529168807 cites W1773048998 @default.
• W2529168807 cites W1910154310 @default.
• W2529168807 cites W1917851386 @default.
• W2529168807 cites W1937569197 @default.
• W2529168807 cites W1974551350 @default.
• W2529168807 cites W1981093311 @default.
• W2529168807 cites W1986245753 @default.
• W2529168807 cites W2013392553 @default.
• W2529168807 cites W2022258023 @default.
• W2529168807 cites W2037740708 @default.
• W2529168807 cites W2058322328 @default.
• W2529168807 cites W2122349387 @default.
• W2529168807 cites W2147467901 @default.
• W2529168807 cites W2163089214 @default.
• W2529168807 cites W2216681528 @default.
• W2529168807 cites W2288486409 @default.
• W2529168807 cites W2327053343 @default.
• W2529168807 cites W2335127767 @default.
• W2529168807 cites W2413047276 @default.
• W2529168807 cites W4205879768 @default.
• W2529168807 cites W4210967474 @default.
• W2529168807 doi "https://doi.org/10.1056/nejmoa1605564" @default.
• W2529168807 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27705091" @default.
• W2529168807 hasPublicationYear "2016" @default.
• W2529168807 type Work @default.
• W2529168807 sameAs 2529168807 @default.
• W2529168807 citedByCount "465" @default.
• W2529168807 countsByYear W25291688072016 @default.
• W2529168807 countsByYear W25291688072017 @default.
• W2529168807 countsByYear W25291688072018 @default.
• W2529168807 countsByYear W25291688072019 @default.
• W2529168807 countsByYear W25291688072020 @default.
• W2529168807 countsByYear W25291688072021 @default.
• W2529168807 countsByYear W25291688072022 @default.
• W2529168807 countsByYear W25291688072023 @default.
• W2529168807 crossrefType "journal-article" @default.
• W2529168807 hasAuthorship W2529168807A5004411977 @default.
• W2529168807 hasAuthorship W2529168807A5006848901 @default.
• W2529168807 hasAuthorship W2529168807A5009530648 @default.
• W2529168807 hasAuthorship W2529168807A5009670740 @default.
• W2529168807 hasAuthorship W2529168807A5016803527 @default.
• W2529168807 hasAuthorship W2529168807A5019448758 @default.
• W2529168807 hasAuthorship W2529168807A5021863965 @default.
• W2529168807 hasAuthorship W2529168807A5032912238 @default.
• W2529168807 hasAuthorship W2529168807A5034754979 @default.
• W2529168807 hasAuthorship W2529168807A5035047139 @default.
• W2529168807 hasAuthorship W2529168807A5040987821 @default.
• W2529168807 hasAuthorship W2529168807A5042412197 @default.
• W2529168807 hasAuthorship W2529168807A5048048876 @default.
• W2529168807 hasAuthorship W2529168807A5053007723 @default.
• W2529168807 hasAuthorship W2529168807A5054373500 @default.
• W2529168807 hasAuthorship W2529168807A5055603714 @default.
• W2529168807 hasAuthorship W2529168807A5062797338 @default.
• W2529168807 hasAuthorship W2529168807A5067236730 @default.
• W2529168807 hasAuthorship W2529168807A5086053655 @default.
• W2529168807 hasAuthorship W2529168807A5087193991 @default.
• W2529168807 hasBestOaLocation W25291688071 @default.
• W2529168807 hasConcept C116675565 @default.
• W2529168807 hasConcept C119060515 @default.
• W2529168807 hasConcept C126322002 @default.
• W2529168807 hasConcept C141071460 @default.
• W2529168807 hasConcept C151730666 @default.
• W2529168807 hasConcept C159047783 @default.
• W2529168807 hasConcept C203014093 @default.
• W2529168807 hasConcept C2522874641 @default.
• W2529168807 hasConcept C2777053367 @default.
• W2529168807 hasConcept C2778691916 @default.
• W2529168807 hasConcept C2779343474 @default.
• W2529168807 hasConcept C2779618896 @default.
• W2529168807 hasConcept C71924100 @default.
• W2529168807 hasConcept C86803240 @default.
• W2529168807 hasConceptScore W2529168807C116675565 @default.
• W2529168807 hasConceptScore W2529168807C119060515 @default.

• next